Helpline 0300 111 4748

KS patients younger than 16 should not be offered fertility preservation

Klinefelter syndrome (KS) patients younger than 16 should not be offered fertility preservation, according to a new evidence review.

NEW YORK (Reuters Health) – Klinefelter syndrome (KS) patients younger than 16 should not be offered fertility preservation, according to a new evidence review.

Germ cell retrieval rate by testicular sperm extraction (TESE) is far lower in these younger KS patients compared to those aged 16 to 30, Dr. Sebastian Franik of Radboudumc in Nijmegen, the Netherlands, and colleagues report in Human Reproduction, online July 13.

“Despite the current evidence that testicular degeneration seems to accelerate with the onset of puberty, there is no evidence that spermatogenesis seems to be impaired by this degeneration,” Dr. Franik told Reuters Health by email.

“There is no need for early fertility preservation before or during puberty,” he added. “Early fertility preservation might even lower the chances for spermatogenesis by removing stem cells that would have had developed into sperm otherwise.”

 

 

www.medscape.com/viewarticle/867152?src=wnl_edit_tpal&uac=202468AG

Recent Posts

Programme for KSA Conference and AGM

Full programme for KSA Conference and AGM 2024 Please note that timings are for guidance only and may change on the day. Delegates attending virtually will be unable to view Workshops 1A, 2A and 3A. Saturday, 18th May 2024 9.00

Read More

Fertility Conference 2024

On Thursday 11th of January, KSA Trustee Claire Harkin attended the 2024 Fertility Conference in Edinburgh as a day delegate and gave a Rapid-Fire Poster Presentation on “Experiences of infertility among people with Klinefelter syndrome/XXY.”

Read More

Barry (Badger) Duplock

6/12/1968-18/6/2023.
Barry was born to Gladys and Bill Duplock in South Africa. When he was 3, they moved to Rhodesia (later known as Zimbabwe).

Read More

Availability of gels

There still seems to be difficulty obtaining some of the testosterone gels. We have been notified by Androlabs that the supply of Testavan gel has not been affected. If you or your medical advisor would like more information please see

Read More